"Diabetes Mellitus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
Descriptor ID |
D003920
|
MeSH Number(s) |
C18.452.394.750 C19.246
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Diabetes Mellitus".
Below are MeSH descriptors whose meaning is more specific than "Diabetes Mellitus".
This graph shows the total number of publications written about "Diabetes Mellitus" by people in this website by year, and whether "Diabetes Mellitus" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 2 | 1 | 3 |
1995 | 3 | 2 | 5 |
1996 | 0 | 1 | 1 |
1997 | 1 | 0 | 1 |
1998 | 0 | 1 | 1 |
1999 | 3 | 5 | 8 |
2000 | 1 | 1 | 2 |
2001 | 4 | 2 | 6 |
2002 | 3 | 3 | 6 |
2003 | 8 | 7 | 15 |
2004 | 9 | 6 | 15 |
2005 | 8 | 9 | 17 |
2006 | 7 | 9 | 16 |
2007 | 11 | 4 | 15 |
2008 | 8 | 6 | 14 |
2009 | 9 | 7 | 16 |
2010 | 15 | 9 | 24 |
2011 | 16 | 21 | 37 |
2012 | 21 | 8 | 29 |
2013 | 15 | 17 | 32 |
2014 | 12 | 13 | 25 |
2015 | 17 | 10 | 27 |
2016 | 20 | 18 | 38 |
2017 | 13 | 13 | 26 |
2018 | 15 | 10 | 25 |
2019 | 28 | 10 | 38 |
2020 | 33 | 7 | 40 |
2021 | 30 | 8 | 38 |
2022 | 79 | 2 | 81 |
2023 | 82 | 1 | 83 |
2024 | 12 | 0 | 12 |
To return to the timeline,
click here.
Below are the most recent publications written about "Diabetes Mellitus" by people in Profiles.
-
Epidemiology and Prognostic Implications of Coronary Artery Calcium in Asymptomatic Individuals With Prediabetes: A Multicohort Study. Diabetes Care. 2024 Apr 01; 47(4):698-706.
-
Galectin-3, Metabolic Risk, and Incident Heart Failure: The ARIC Study. J Am Heart Assoc. 2024 Mar 19; 13(6):e031607.
-
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial. Lancet. 2024 Mar 23; 403(10432):1153-1163.
-
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2023 American Heart Association Scientific Sessions. Curr Atheroscler Rep. 2024 Apr; 26(4):119-131.
-
The infected diabetic foot: Modulation of traditional biomarkers for osteomyelitis diagnosis in the setting of diabetic foot infection and renal impairment. Int Wound J. 2024 Mar; 21(3):e14770.
-
Determining a urinary-specific antibiogram and risk factors of trimethoprim/sulfamethoxazole, ciprofloxacin and multidrug resistance among Enterobacterales in primary care. J Antimicrob Chemother. 2024 Mar 01; 79(3):559-563.
-
Metabolomic profiles of sleep-disordered breathing are associated with hypertension and diabetes mellitus development. Nat Commun. 2024 Feb 28; 15(1):1845.
-
Detection and Management of Perioperative Hyperglycemia at a Tertiary Cancer Center. Ann Surg Oncol. 2024 May; 31(5):3017-3023.
-
Association of cardiovascular risk profile with premature all-cause and cardiovascular mortality in US adults: findings from a national study. BMC Cardiovasc Disord. 2024 Feb 06; 24(1):91.
-
Offloading and adherence through technological advancements: Modern approaches for better foot care in diabetes. Diabetes Metab Res Rev. 2024 Feb; 40(2):e3769.